Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

140.91
Delayed Data
As of Dec 12
 -0.77 / -0.54%
Today’s Change
71.46
Today|||52-Week Range
167.86
+91.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues458.7M714.7M544.1M578.2M
 
 
 
 
 
Cost of Goods Sold45.0M32.1M56.3M57.6M
 
 
 
 
 
Depreciation And Amortization15.5M14.9M14.9M15.2M
 
 
 
 
 
 
Operating ExpensesGross Income398.2M667.7M472.9M505.3M
 
 
 
 
 
General Expenses358.4M386.9M416.7M575.7M
 
 
 
 
 
Research And Development248.5M273.6M289.5M454.9M
 
 
 
 
 
Total Operating Expenses418.8M433.9M487.9M648.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income39.9M280.8M56.2M-70.4M
 
 
 
 
 
Extraordinary Charge-224.0K-10.0M-3.5M-259.8M
 
 
 
 
 
Interest Expense On Debt20.4M16.8M14.7M13.6M
 
 
 
 
 
Other Expenses1.1M-544.0K-2.5M-73.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income20.3M253.5M35.5M-417.2M
 
 
 
 
 
Income Taxes-7.5M-4.0M-4.3M-125.9M
 
 
 
 
 
Minority Interest-5.2M-1.8M-13.2M-188.3M
 
 
 
 
 
Net Income32.9M247.4M18.0M-103.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS245.5M246.0M247.5M250.3M
 
 
 
 
 
Shares To Calculate EPS Diluted247.8M248.7M251.6M250.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.13$0.99$0.07-$0.41
 
 
 
 
 
EPS Diluted$0.13$0.99$0.07-$0.41